Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells

Journal of Neurochemistry

Volumn 126, Issue 3, 2013, Pages 318-330

  Chen, Can ^a   Wang, Yi ^a   Goh, Sally S L ^a   Yang, Jing ^a   Lam, Dang Hoang ^a,b   Choudhury, Yukti ^b   Tay, Felix Chang ^a   Du, Shouhui ^a   Tan, Wee Kiat ^a   Purwanti, Yovita Ida ^a,b   Fan, Weimin ^c   Wang, Shu ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Boyden chamber assay; microarray analysis; Neural stem cells; neuronal nitric oxide synthase; tumor tropism

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TROPISM;

BOYDEN CHAMBER ASSAY; MICROARRAY ANALYSIS; NEURAL STEM CELLS; NEURONAL NITRIC OXIDE SYNTHASE; TUMOR TROPISM;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, NUDE; NEOPLASMS; NEURAL STEM CELLS; NITRIC OXIDE SYNTHASE TYPE I; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84880570864     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12199     Document Type: Article

References (33)

1. Aboody K. S., Brown A., Rainov N. G., et al,. (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl Acad. Sci. USA 97, 12846-12851.
2. Aboody K. S., Bush R. A., Garcia E., et al,. (2006) Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE 1, e23.
3. Aboody K. S., Najbauer J., and, Danks M. K., (2008) Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15, 739-752.
4. Brown A. B., Yang W., Schmidt N. O., Carroll R., Leishear K. K., Rainov N. G., Black P. M., Breakefield X. O., and, Aboody K. S., (2003) Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 14, 1777-1785.
5. Ciani E., Severi S., Contestabile A., and, Bartesaghi R., (2004) Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation. J. Cell Sci. 117, 4727-4737.
6. Jurvansuu J., Zhao Y., Leung D. S., Boulaire J., Yu Y. H., Ahmed S., and, Wang S., (2008) Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Cancer Res. 68, 4614-4622.
7. Kaminski A., Pohl C. B., Sponholz C., Ma N., Stamm C., Vollmar B., and, Steinhoff G., (2004) Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am. J. Pathol. 164, 2241-2249.
8. Kasper G., Mao L., Geissler S., et al,. (2009) Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27, 1288-1297.
9. Kosztowski T., Zaidi H. A., and, Quinones-Hinojosa A., (2009) Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev. Anticancer Ther. 9, 597-612.
10. Lee E. X., Lam D. H., Wu C., Yang J., Tham C. K., Ng W. H., and, Wang S., (2011) Glioma gene therapy using induced pluripotent stem cell derived neural stem cells. Mol. Pharm. 8, 1515-1524.
11. Luo C. X., Jin X., Cao C. C., Zhu M. M., Wang B., Chang L., Zhou Q. G., Wu H. Y., and, Zhu D. Y., (2010) Bidirectional regulation of neurogenesis by neuronal nitric oxide synthase derived from neurons and neural stem cells. Stem Cells 28, 2041-2052.
12. Maeda Y., Ikeda U., Oya K., Shimpo M., Ueno S., Okada K., Saito T., Mano H., Ozawa K., and, Shimada K., (2000) Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibits cellular proliferation. J. Pharmacol. Exp. Ther. 292, 387-393.
13. Moreno-Lopez B., Noval J. A., Gonzalez-Bonet L. G., and, Estrada C., (2000) Morphological bases for a role of nitric oxide in adult neurogenesis. Brain Res. 869, 244-250.
14. Muller F. J., Snyder E. Y., and, Loring J. F., (2006) Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci. 7, 75-84.
15. Nakatsuji N., (2010) Banking human pluripotent stem cell lines for clinical application? J. Dent. Res. 89, 757-758.
16. Narsinh K. H., Plews J., and, Wu J. C., (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol. Ther. 19, 635-638.
17. Nishikawa S., Goldstein R. A., and, Nierras C. R., (2008) The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell Biol. 9, 725-729.
18. Overend J., and, Martin W., (2007) Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery. Br. J. Pharmacol. 150, 488-493.
19. Patel M., and, Yang S., (2010) Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 6, 367-380.
20. Rakshit S., Bagchi J., Mandal L., Paul K., Ganguly D., Bhattacharjee S., Ghosh M., Biswas N., Chaudhuri U., and, Bandyopadhyay S., (2009) N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide. Apoptosis 14, 298-308.
21. Sommer C. A., Stadtfeld M., Murphy G. J., Hochedlinger K., Kotton D. N., and, Mostoslavsky G., (2009) Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543-549.
22. Sommer C. A., Sommer A. G., Longmire T. A., Christodoulou C., Thomas D. D., Gostissa M., Alt F. W., Murphy G. J., Kotton D. N., and, Mostoslavsky G., (2010) Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64-74.
23. Su Y., Kondrikov D., and, Block E. R., (2005) Cytoskeletal regulation of nitric oxide synthase. Cell Biochem. Biophys. 43, 439-449.
24. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and, Yamanaka S., (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
25. Tamaoki N., Takahashi K., Tanaka T., et al,. (2010) Dental pulp cells for induced pluripotent stem cell banking. J. Dent. Res. 89, 773-778.
26. Taupin P., (2007) Potential of adult neural stem cells for cellular therapy. Biologics 1, 53-58.
27. Tegenge M. A., and, Bicker G., (2009) Nitric oxide and cGMP signal transduction positively regulates the motility of human neuronal precursor (NT2) cells. J. Neurochem. 110, 1828-1841.
28. Tegenge M. A., Rockel T. D., Fritsche E., and, Bicker G., (2011) Nitric oxide stimulates human neural progenitor cell migration via cGMP-mediated signal transduction. Cell. Mol. Life Sci. 68, 2089-2099.
29. Wu S. M., and, Hochedlinger K., (2011) Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13, 497-505.
30. Yang J., Lam D. H., Goh S. S., et al,. (2012) Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. Stem Cells 30, 1021-1029.
31. Zhang R., Zhang L., Zhang Z., Wang Y., Lu M., Lapointe M., and, Chopp M., (2001) A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann. Neurol. 50, 602-611.
32. Zhang P., Liu Y., Li J., Kang Q., Tian Y., Chen X., Zhao J., Shi Q., and, Song T., (2007) Decreased neuronal nitric oxide synthase expression and cell migration in the peri-infarction after focal cerebral ischemia in rats. Neuropathology 27, 347-354.
33. Zhao Y., Lam D. H., Yang J., Lin J., Tham C. K., Ng W. H., and, Wang S., (2012) Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. Gene Ther. 19, 189-200.